| |
| |
|
| Insider
Information: |
Cardama Alfonso Quintas |
| Relationship: |
Chief Medical Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tcr2 Therapeutics Inc. |
TCRR |
Chief Medical Officer |
2023-06-01 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(109,459) |
0 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-13 |
4 |
AS |
$1.06 |
$5,042 |
D/D |
(4,752) |
109,459 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-12 |
4 |
AS |
$1.10 |
$5,040 |
D/D |
(4,586) |
114,211 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-09 |
4 |
AS |
$1.13 |
$5,041 |
D/D |
(4,461) |
118,797 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-08 |
4 |
AS |
$1.26 |
$5,042 |
D/D |
(4,014) |
123,258 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-07 |
4 |
AS |
$1.28 |
$5,040 |
D/D |
(3,928) |
127,272 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-06 |
4 |
AS |
$1.33 |
$5,040 |
D/D |
(3,778) |
131,200 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-05 |
4 |
AS |
$1.37 |
$5,050 |
D/D |
(3,686) |
134,978 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-02 |
4 |
AS |
$1.39 |
$5,054 |
D/D |
(3,636) |
138,664 |
0 |
% |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,385 |
142,300 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-12-09 |
4 |
OE |
$0.74 |
$31,820 |
D/D |
43,000 |
46,915 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-08-31 |
4 |
A |
$14.26 |
$2,339 |
D/D |
164 |
3,915 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-02-28 |
4 |
A |
$16.12 |
$11,416 |
D/D |
708 |
3,751 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-08-31 |
4 |
A |
$10.10 |
$11,290 |
D/D |
1,118 |
3,043 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-02-28 |
4 |
A |
$10.10 |
$10,928 |
D/D |
1,082 |
1,925 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-08-30 |
4 |
A |
$12.75 |
$10,748 |
D/D |
843 |
843 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
